United Scientific Group hosted 2nd International Conference on Addiction Medicine and Reward Deficiency Syndrome (ARDS 2017) in Baltimore, MD, USA during March 17-19, 2017, unfolding the varied facets of Addiction Medicine – It’s Research and Therapy. This 3-day scientific gathering with theme – Neurobiological and Clinical Science: Changing the Landscape of Addiction Medicine and Recovery, laid a global platform to share the current scenario of addiction to alcohol, opioids, substance abuse besides enlightening pathways to combat addiction to various substances.
After successful completion of Inaugural Reward Deficiency Syndrome Summit (RDS-1) in San Francisco on November 16-18, 2015, the first ever conference devoted to the Reward Deficiency Syndrome (RDS) an emerging field, we opened the gates to witness and share cutting-edge scientific findings, medical practices and caregiver initiatives related to addiction research and therapy through ARDS 2017.
In the course of the three-days, the attendees got an exclusive opportunity to network and be involved in inspiring and interesting discussions of latest information. The conference has gathered keynote lectures from 14 top notch experts from the field of addiction medicine, psychiatry and neurobiology and 47 speakers from sessions spanning across topics of current research like addiction genetics, drug addiction, eating disorders, gambling studies, child & adolescent substance abuse, dual diagnosis, neurotoxicology, drug induced brain disorders and new insights in addiction treatment & rehabilitation and their significance in clinical research and health diagnostics. The conference has provided the platform for Dominion Diagnostics, USA and Peak Achievement Training, USA, Nupathways, USA to exhibit their products and services. Travel sponsor for the event was Synaptamine Inc., USA.
The event witnessed valuable talks from renowned experts through keynote speeches, special evening talk on Evidence-based holistic modalities to overcome addictions, a special talk emphasizing Opioid Substitution Treatment, a panel discussion on Reward genomic disparity in opiate/opioid dependent African Americans embracing ‘dopamine homeostasis’ through epigenetic manipulation, the debate constituted 9 top notch experts from field of Addiction, Psychiatry and Neurobiology. The conference got concluded on a good note through special session – Clinical and Pre-Clinical Aspects of Alcohol Addiction following Bariatric Surgery.
The ARDS-2017 organizing committee were contended that the conference was accredited by Wright State University for CME Credits: 19 AMA PRA Category 1 Credit(s)™ and participants benefited from the high value scientific program and foster new and lasting cross-disciplinary partnerships and collaborations between researchers, physicians, academicians, drug-experts, clinicians, policy makers in disparate biomedical and health science field to improve the knowledge sharing, with the goal of promoting the identification and deployment of effective treatment and recovery strategies for addiction.